Oxford AstraZeneca Covid-19 vaccine ‘preventing lagged rise in deaths’
Clive Dix said the durable cellular immunity response produced by the AZ jab can potentially ‘last for life’.
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.The use of the Oxford AstraZeneca Covid-19 vaccine in vulnerable people may be resulting in a lower death toll in the UK compared to Europe according to the former chief of the country’s vaccine taskforce.
Clive Dix said the durable cellular immunity response produced by the AZ jab can potentially “last for life”.
The Oxford/AstraZeneca jab was approved last December, and vaccines were initially rolled out among the older and the most vulnerable in society.
Mr Dix told The Daily Telegraph: “If you look across Europe, with the rise in cases, there’s also a corresponding lagged rise in deaths, but not in the UK, and we have to understand that.”
He added: “I personally believe that’s because most of our vulnerable people were given the AstraZeneca vaccine.”
Mr Dix told the newspaper: “We’ve seen early data that the Oxford jab produces a very durable cellular response and if you’ve got a durable cellular immunity response then they can last for a long time.
“It can last for life in some cases.”
AstraZeneca has faced both praise and criticism during the pandemic, with its Covid jab hailed as being one of the first on the market and for its low cost in comparison to other jabs.
The rollout of the Oxford/AstraZeneca jab in the UK saw Government advisers recommending under-40s should be offered alternatives due to evidence it may be linked to very rare blood clots.
Fears over links to blood clots also saw some European countries pause their use of the jab.
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.